It remains unknown whether there are distinct radiologic features associated with KRAS G12C NSCLC that may provide insights into biology and metastatic potential of this driver mutation, which may in turn inform surveillance and imaging strategies. Here, KRAS is linked to non-small cell lung carcinoma.